Chanakya Ni Pothi - November 24, 2025

Bu sayıda

Why CHANAKYA is truly VALUE FOR MONEY?
This week’s issue delivers unmatched depth across IPOs, markets, sectors and fast-moving trading opportunities.
Pages 22–24: Detailed analysis of Sudeep Pharma mainboard IPO, 5 SME IPOs, and 2 NCD issues. A special report on Adani Enterprises Rights Issue is also included. Comprehensive Grey Market trends, forthcoming listing estimates, and subscription status of all live IPOs are covered in detail.
Chanakya Exclusive: Our Technical Research Team has identified 29 high-potential scrips that can generate strong gains within 4–6 weeks. No other publication offers such powerful, insider-level technical insight.
Trading Opportunities: • 3 Short-Selling ideas on Page 6 • Large-Cap Bull Cartel picks (Page 3) • Midcap Bull Cartel picks (Pages 7–8)
Sector & Global Coverage: Pages 11–13 deliver a complete World Market Report aligned with the Indian context, plus sector analysis across Automobiles, Components, New-Age stocks and Healthcare — with both short-term and long-term outlooks.
Fundamental Insights: Exclusive expert research on Ajax Engineering, Dollar Industries, Vishal Mega Mart, NBCC, One Source Speciality Chemicals, Rubicon Research, Honasa, Akum Drugs and Lupin.
Mutual Fund Review: Detailed MF analysis on Page 17.
Market Gupshup: Insider chatter and sharp observations on Pages 22 & 24.
Other Key Features: Nifty & Bank Nifty trends, Gold–Silver–Crude outlook (Page 2), Dow Jones & Currency analysis (Page 15).
Chanakya remains the ONLY publication in India that blends deep Fundamental Research with high-conviction, technically-identified Fast-Moving Scrips. Truly – VALUE FOR MONEY!